OpenLegislation

Paragraph 3 I1

United Kingdom

For regulation 17 (amendment of regulation 36 (requirement for authorisation to manufacture or import investigational medicinal products)) substitute—

“17

In regulation 36(2), after “marketing authorization” insert “ or marketing authorisation issued by the competent authority of an EEA State in accordance with Directive 2001/83/EC ”.”.

Annotations

Commencement

I1

Sch. 1 para. 3 in force at 31.12.2020 immediately before IP completion day, see reg. 1